Inventor · disambiguated record
Karim Benhadji
Also filed as: BENHADJI KARIM · BENHADJI KARIM A · BENHADJI KARIM ADNANE
2 granted patents·7 pending applications·8 citations·filing 2016–2022
54Inventor score
Top patents by PatentIndex Score
9 records- 0182US10555951B2Targeted treatment of leiomyosarcomaLILLY CO ELI·Filed 2016·Granted Feb 11, 2020·6 cites·9 claims
- 0267US11376259B2Targeted treatment of mature T-cell lymphomaLILLY CO ELI·Filed 2017·Granted Jul 5, 2022·2 cites·14 claims
- 0357US2024408100A1Treatment methods for subjects having cancer with a dysregulated mapk and/or pi3k pathwayTAIHO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0456US2022296607A1Targeted treatment of mature t-cell lymphomaLILLY CO ELI·Filed 2022·Application pending·0 cites
- 0555US2024122937A1Treating cancer in patient with pten inactivating mutationTAIHO PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0648US2024165120A1Treating cancer in patient having co-occurring genetic alteration in fgfr2 and a cancer driver geneTAIHO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0745US2024238300A1Treatment methods for subjects with cancer having an aberration in egfr and/or her2KREMER JILL·Filed 2022·Application pending·0 cites
- 0843US2019216786A1USE OF 2-{4-[(4-{[1-CYCLOPROPYL-3-TETRAHYDRO-2H-PYRAN-4-yl)-1H-PYRAZOL-4yl]OXY} PYRIDINE-2-yl)AMINO]PYRIDIN-2-yl}PROPAN-2-OL IN THE TREATMENT OF CANCERLILLY CO ELI·Filed 2017·Application pending·0 cites
- 0937US2019209581A1Dosage regimen for treatment of solid tumorsLILLY CO ELI·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Karim Benhadji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →